Peakview Capital
盛景嘉成
Peakview Capital (高榕资本) is a Chinese venture capital firm whose portfolio spans frontier tech, consumer, healthcare, and enterprise services, according to a 2022 Gaorong Ventures monthly recap . The fund has made early bets in companies such as Zhanlue Data (栈略数据), an insurtech player applying RPA and AI to health insurance, where it participated in the 2016 angel round and 2017 Series A , and BioGeometry (百奥几何), a generative-AI protein-design startup where it led the 2022 angel round and re-upped in a 2024 pre-A . elsewhere's corpus does not cover the firm's founding date, team, or assets under management.
AI-generated — may contain errors, please verify.
Coverage
Rongbao | Generative AI Powers Industries, Snack Chains Hit 10,000 Stores, Chip Tape-Out Success, Healthcare Goes Global
Innovation lights the path to growth.
BioGeometry Completes Pre-A Round, Applying Generative AI to Bio-Manufacturing
Continuously optimizing a generative AI-powered protein design platform.
Gaorong Monthly · December | Gaorong Ventures and Its Frontier Tech / Consumer / Healthcare / Enterprise Service Portfolio Companies Win Multiple Annual Awards
Its technological and innovative capabilities have won recognition.
